BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'COVID-19 vaccine'. (Return)

Google Business NewsAug 02, 2020
Scientists Worry About Political Influence Over Coronavirus Vaccine Project - The New York Times
Scientists Worry About Political Influence Over Coronavirus Vaccine Project  The New York TimesWho will be first in line for a COVID-19 vaccine?  KTRK-TVHere's How to Register For a Chance to Participate in the Covid-19 Vaccine Trial  NBC Southern CaliforniaHow vaccine nationalism is hampering efforts to end COVID-19 pandemic  Moneycontrol

Yahoo BusinessAug 02, 2020
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY) GlaxoSmithKline plc (NYSE: GSK) won a joint $2.1 billion U.S. federal funding award.Here're the key catalysts for the unfolding week:Conferences72nd National Hemophilia Foundation's Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8PDUFA DatesFDA is scheduled to rule on DBV TECHNOLOGIE/S' ADR (NASDAQ: DBVT) Viaskin peanut allergy patch Wednesday. However, cancellation of the Adcom meeting scheduled May 15 has poured cold water on the prospects of an approval coming through.Trevena Inc (NASDAQ: TRVN) has a tryst with the FDA Friday, with respect to the NDA for its pain drug oleceridine, which was once rejected by the agency on the premise of inadequacy of clinical data.FDA is also due to rule on Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) exertional heat stroke drug ryanodex Saturday. The original PDUFA date was pushed back a month as the FDA finds it hard to keep up with scheduling commitments due to COVID-19.Clinical ReadoutsBioSig Technologies Inc's (NASDAQ: BSGM) CEO Kenneth Londoner, will present at the Proactive Investors One2One Virtual Event Tuesday an update on Phase 2 clinical study of merimepodib in combination with remdesiv
TRENDING TAGS
TikTokMicrosoft Trump Chinese Talks Buy
TrumpTikTok Microsoft about Chinese Pick
CoronavirusBirx cases phase About Vaccine
MicrosoftTikTok Trump Talks Buy Deal
Covid-19cases positive Georgia tests deaths
Pandemiccoronavirus Birx warns phase Lord
BuyStock Microsoft TikTok Stocks owner
Billion7-Eleven Marathon Buy Owner Speedway
Filesbankruptcy Lord & Taylor retail
casesCoronavirus Covid-19 live deaths additional

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC